SCHEMBL4384182

SCHEMBL4384182

CCC(=O)c1c(OCOC)cc(OCOC)c(-c2ccccc2)c1CCOC

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.40
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 5/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 5/20 0.34
NPC1 O15118 2/20 0.34
HPGD P15428 2/20 0.34
RAB9A P51151 2/20 0.34
CAPN1 P07384 2/20 0.33
GAA P10253 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 1/20 0.32
AHR P35869 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PADI4 Q9UM07 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381558 0.89 EGFR (0.45) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL4384151 0.88 EGFR (0.42) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL2867378 0.87 EGFR (0.44) EGFRTP53MAPTL3MBTL1KDM4E
SCHEMBL4386770 0.87 LMNA (0.41) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL4395195 0.85 EGFR (0.40) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL4388307 0.84 EGFR (0.39) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL4386937 0.83 EGFR (0.40) EGFRTP53SMN1; SMN2MAPTL3MBTL1
SCHEMBL4381699 0.82 EGFR (0.44) EGFRTP53MAPTKDM4EMEN1
SCHEMBL4384178 0.81 EGFR (0.42) EGFRTP53SMN1; SMN2L3MBTL1KDM4E
SCHEMBL4381829 0.81 EGFR (0.38) EGFRTP53SMN1; SMN2L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P EGFR 624/4885TP53 918/4885SMN1; SMN2 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.